XRTX
NASDAQ
$2.01
XORTX Therapeutics Inc (XRTX)
XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease, hypertension, insulin resistance, and diabetic nephropathy. The company is headquartered in Vancouver, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Target: $14.04 (+598.51%)
Market Cap
$3.34M
Free Cash Flow Yield
-68.74%
Beta (5Y)
0.61
Price Chart
Valuation
Market Cap$3.34M
Forward P/E0.96
P/B3.05
Profitability
EBITDA-$2.15M
Financial Health
Debt-to-Equity1.2%
Free Cash Flow Yield-68.74%
Growth & Risk
FCF 5Y CAGR+5.82%
Beta (5Y)0.61
Sharpe Ratio-0.42